PRaG-1 Plus PRaG Therapy in Advanced Solid Tumors: A Prospective Clinical Trial (PRaG 10.0)

NCT07267234 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

65

Enrollment

OTHER

Sponsor class

Conditions

Solid Cancer
Lymphopenia
Radiotherapy
Immune Checkpoint Inhibitor

Interventions

DRUG: PD -1/PD-L1 monoclonal antibody

Sponsor

Second Affiliated Hospital of Soochow University